Ranbaxy shines with subsidiary’s launch of authorized version of Caduet in US
source: http://profit.ndtv.com/News/Article/Ranbaxy-shines-with-subsidiary-s-launch-of-authorized-ve...
Ranbaxy Laboratories is currently trading at Rs 442.00, up by 5.60 points or 1.28 per cent from its previous closing of Rs 436.40 on the BSE.The scrip opened at Rs 441.95 and has touched a high and low of Rs 444.10 and Rs 441.00 respectively. So far 27,000 shares were traded on the counter.
link:http://profit.ndtv.com/News/Article/Ranbaxy-shines-with-subsidiary-s-launch-of-authorized-version-of-Caduet-in-US-161326-293603
link:http://profit.ndtv.com/News/Article/Ranbaxy-shines-with-subsidiary-s-launch-of-authorized-version-of-Caduet-in-US-161326-293603
-
- groups:
- World News
